Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1075 of 5804
-
New pill aims to stop nausea caused by popular Weight-Loss drugs
Symptom relief Recruiting nowThe goal of this study is to measure the effects of using Tradipitant to treat nausea and vomiting induced by GLP-1R agonist use in adults with class I or class II obesity, or adults who are overweight with at least one weight-related condition. The study is placebo-controlled wi…
Phase: PHASE3 • Sponsor: Vanda Pharmaceuticals • Aim: Symptom relief
Last updated Jun 27, 2026 12:10 UTC
-
New drug cocktail aims to shrink Hard-to-Treat breast tumors
Disease control Recruiting nowThis study aims to evaluate the safety, tolerability, efficacy and pharmacokinetics of HRS-6208 in combination with HRS-8080 ± HRS-6209, or in combination with fulvestrant ± HRS-6209, or in combination with letrozole ± HRS-6209 in patients with advanced unresectable or metastatic…
Phase: PHASE1, PHASE2 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New cocktail therapy targets rare cancer after standard treatment fails
Disease control Recruiting nowThis is a single-arm, multicenter phase Ⅱ study to evaluate the therapeutic efficacy and safety of chidamide + sintilimab + bevacizumab in subjects with advanced extrapulmonary neuroendocrine carcinoma who have failed first-line standard therapy. The primary purpose is to assess …
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Blood product showdown: which stops bleeding faster in heart surgery?
Disease control Recruiting nowThe primary endpoint of this study is the completion time of hemostasis treatment when administered Fresh frozen plasma (FFP) and frozen powder coagulation factor concentrate (PCC) in goal-directed bleeding management for cardiac surgery.
Phase: PHASE4 • Sponsor: Konkuk University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Milkshake diet could boost Crohn's treatment in kids
Disease control Recruiting nowCrohn's disease (CD) is a chronic, incurable condition associated with gut inflammation. Two important treatments currently used to manage CD are special drug injections (biologics) or a liquid-only diet using specialised milkshakes. However, treatment with biologics is only succ…
Phase: NA • Sponsor: University of Glasgow • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New drug cocktail aims to boost bile duct cancer treatment
Disease control Recruiting nowBased on preclinical data from the Lim lab (WUSM), the investigators hypothesize that IRAK4 inhibition cripples tumor-intrinsic survival signaling and effectively overcomes the desmoplastic and immune-suppressive tumor microenvironment (TME) to render chemo- and immunotherapies e…
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New lupus shot aims to tame flares in phase 2 trial
Disease control Recruiting nowThis was a multicenter, randomized, double-blind, placebo-controlled Phase 2 clinical study. The primary objective was to evaluate the efficacy of SG301 SC injection in participants with Systemic Lupus Erythematosus (SLE) based on the Systemic Lupus Erythematosus Responder Index …
Phase: PHASE2 • Sponsor: Hangzhou Sumgen Biotech Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Can an arthritis drug restore joy in depression?
Symptom relief Recruiting nowThe proposed study aims to establish the feasibility and safety of subcutaneous tocilizumab, a monoclonal antibody (mAb) against interleukin (IL)-6 receptor, in adults with Major Depressive Disorder (MDD) and evidence of peripheral immune activation. IL-6 is a pro-inflammatory cy…
Phase: PHASE2 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
New pill shows promise for rare joint tumor in early trial
Disease control Recruiting nowThe primary purpose of this study is to assess the tolerability, pharmacokinetics, and efficacy of pimicotinib in Japanese participants with TGCT
Phase: PHASE2 • Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Could a sleep hormone help fight superbugs?
Disease control Not yet recruitingThis study evaluates whether adding melatonin to standard colistin therapy improves outcomes in patients with multidrug-resistant (MDR) Gram-negative bacterial infections. These infections are difficult to treat and are associated with high morbidity and mortality, particularly i…
Phase: PHASE3 • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Could a neck zap fix swallowing after a breathing tube?
Disease control Not yet recruitingDysphagia can reach a prevalence of up to 80% in intensive care patients. The implementation or prolonged presence of medical devices such as the intubation tube, tracheostomy, or nasogastric tube alters the physiology of swallowing and causes local injuries at several levels. Ad…
Phase: NA • Sponsor: Hopital Forcilles • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Could a simple supplement tame diabetes and heart risk?
Disease control Not yet recruitingThis study evaluates the effectiveness and safety of tributyrin supplementation in patients with type 2 diabetes mellitus (T2DM) who are at increased risk of cardiovascular disease. Type 2 diabetes is commonly associated with poor blood sugar control, chronic inflammation, oxidat…
Phase: PHASE3 • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New heart valve repair device offers hope without surgery
Disease control Recruiting nowTo confirm the effectiveness and safety of the GeminiOne Transcatheter Mitral Valve Repair System for the treatment of severe, symptomatic mitral regurgitation.
Phase: NA • Sponsor: Sierra Valve LLC • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Could a simple chemical wash replace surgery for trapped lungs?
Disease control CompletedThe purpose of this study is to compare the clinical and radiological efficacy of chemical pleural adhesiolysis (using either intrapleural 3% hydrogen peroxide or intrapleural corticosteroids) versus mechanical pleural adhesiolysis (via medical thoracoscopy) in patients with non-…
Phase: PHASE2 • Sponsor: Delta University for Science and Technology • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Quitting smoking may be easier when someone helps with life's other struggles — a trial puts the idea to the test
Disease control Recruiting nowBackground: The goal of this study is to address parental smoking and social adversity, which can present an obstacle for smoking cessation, in order to decrease childhood exposure to second-hand cigarette smoke. To address these factors, this study includes a smoking cessation i…
Phase: NA • Sponsor: St. Justine's Hospital • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New drug zigakibart aims to slow kidney disease in IgA nephropathy patients
Disease control Recruiting nowThe purpose of the study is to assess the effect of zigakibart on IgA nephropathy (IgAN) disease progression.
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New hope for chronic hives? experimental drug lesigercept enters Mid-Stage trial
Disease control Recruiting nowThis study aims to evaluate the efficacy and safety of lesigercept in approximately 150 participants with CSU. By enrolling participants with an inadequate response to H1-antihistamines, including those previously treated with omalizumab, this study is expected to provide evidenc…
Phase: PHASE2 • Sponsor: Yuhan Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New pill could tame ulcerative colitis Flare-Ups
Disease control Recruiting nowThe main purpose of this study is to evaluate the safety and effectiveness of LY4268989 when compared to placebo in adult participants with moderately to severely active ulcerative colitis (UC). The study drug will be administered orally. The study will last up to approximately …
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New combo pill aims to melt fat, not muscle, in weight loss
Disease control Recruiting nowThe primary objective of this study is to assess the effect of enobosarm on total body weight
Phase: PHASE2 • Sponsor: Veru Inc. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New rehab program aims to ease Veterans' brain injury symptoms
Symptom relief ENROLLING_BY_INVITATIONThe goal of this clinical trial is to learn if the Avalon Action Alliance Interdisciplinary Outpatient Rehabilitation Program (IORP) can reduce long-lasting symptoms of traumatic brain injury (TBI) and co-occurring disorders in veterans and first responders. The main questions it…
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC